Seeing Is Believing
 
    
                    LYRA is currently covered by 1 analysts with an average price target of $11.82. This is a potential upside of $5.99 (102.74%) from yesterday's end of day stock price of $5.83.
Lyra Therapeutics 's activity chart (see below) currently has 1 price targets and 5 ratings on display. The stock rating distribution of LYRA is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 472.17 days.
Highest price target for LYRA is $16, Lowest price target is $16, average price target is $16.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.
Currently out of the existing stock ratings of LYRA, 3 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$16
$9.63 (151.18%)
$16
2 months 16 days ago
(14-Aug-2025)
0/3 (0%)
$8.9 (125.35%)
Buy
1 years 2 months 15 days ago
(15-Aug-2024)
1/1 (100%)
$9 (150.00%)
1105
Hold
$10
$3.63 (56.99%)
1 years 5 months 23 days ago
(07-May-2024)
1/1 (100%)
$-11 (-52.38%)
190
Hold
$15
1 years 5 months 24 days ago
(06-May-2024)
1/1 (100%)
$11.36 (312.09%)
605
Buy
$10
$3.53 (54.56%)
$11
1 years 5 months 28 days ago
(02-May-2024)
6/6 (100%)
$5.37 (115.98%)
933
What is LYRA (Lyra Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?
Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?
Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?